Silverman, L. | Search bioRxiv

bioRxiv2026

ELMO1 dependent efferocytosis protects from nephrotoxin induced acute kidney injury

Acute kidney injury (AKI) is a sudden episode of kidney failure linked to a wide range of health conditions. High mortality in AKI highlights the need to identify new therapeutic approaches. Homeostasis in multicellular organisms is exquisitely regulated by phagocytosis of apoptotic cells, also known as efferocytosis. Apoptotic cells are frequently observed at sites of inflammation, including in AKI. Engulfment and cell motility protein-1 (ELMO1) is a regulator of the actin cytoskeleton that promotes apoptotic cell removal by phagocytes during efferocytosis. Mutations in the human ELMO1 gene are linked with diabetic nephropathy and, in animal models of this disease, high ELMO1 levels promote renal dysfunction. However, the role of ELMO1 in AKI was not known. Here, we describe the links between ELMO1 and kidney pathology and test global and tissue-specific ELMO1-deficient mice in models of AKI. While global loss of Elmo1 expression did not impact the immediate loss of renal function after ischemia-reperfusion elicited AKI, ELMO1 deficiency resulted in increased tissue injury in AKI caused by cisplatin injection. Cisplatin induced robust renal cell apoptosis that was significantly elevated in mice with the global loss of ELMO1, but not in mice with the macrophage-specific Elmo1 deletion. Using primary cell culture and immunofluorescence approaches, we highlight the role of ELMO1 in efferocytosis by several renal cell types, suggesting possible additive effects during nephrotoxic injury.

pathology↗

bioRxiv2024

Basal p53 maintains a distinct transcriptional program from irradiated p53 in tissue, including tumor suppressors

The significance of p53s primary and secondary tumor suppressor programs cannot be overstated. A context- and stress-dependent transcription factor, p53 accumulates to mount its most well-characterized programs in response to a variety of stressors, most notably DNA damage. As cells and tissues never exist in a complete absence of stress, a small amount of p53 exists in cells under physiologic stress, detectable by chromatin immunoprecipitation and sequencing, termed basal p53. Recently, we and others have shown that basal p53 is sufficient to regulate tumor suppressor function. Furthermore, others have suggested the possibility that p53 accumulation in response to experimental stress may be dispensable for its tumor suppression. We previously showed basal p53 occupancy and regulation of known tumor suppressor genes, including PTEN and PHLDA3, in non-transformed breast cells, but this study was limited by experimental stress inherent to cell culture. Given the lack of global characterization of the basal p53 landscape under non-malignant physiologic stress in vivo, we utilized a multi-omics approach to define the murine basal p53 epigenome and its transcriptional program in various normal murine tissues. In this study, we observed basal p53 binding to cis regions of multiple tumor suppressor genes in different tissues, of which some showed p53-dependent regulation of their expression, including Phlda3, Bbc3, Xaf1, and itself. Furthermore, the vast majority of basal p53 target genes were not induced upon irradiation, suggesting basal p53 operates a transcriptional program that is largely distinct from its DNA damage response. Similarly, the basal p53 target gene repertoire is unique to each tissue type.

biochemistry↗